Starling Oncology, Inc. (STLN): Capital Expenditures

Annual figures by period end, from SEC filings.

$3.20M
Year ended 2025-12-31
$3.61M
Trailing 12 months to 2026-06-30
-16.7%
3-year compound annual growth
+21.8%
5-year compound annual growth
$5.53M2020-12-31: $1.19M2021-12-31: $2.85M2022-12-31: $5.53M2023-12-31: $4.57M2024-12-31: $3.79M2025-12-31: $3.20M$3.20M
2020-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$3.20M-15.5%2026-03-12, From 2025-01-01
2024-12-31$3.79M-17.0%2026-03-12, From 2024-01-01
2023-12-31$4.57M-17.4%2025-03-26, From 2023-01-01
2022-12-31$5.53M+94.2%2024-03-28, From 2022-01-01
2021-12-31$2.85M+138.4%2023-03-16, From 2021-01-01
2020-12-31$1.19Mn/a2022-03-11, From 2020-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Offices & Clinics of Doctors of Medicine), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Starling Oncology, Inc. (STLN)2025-12-31$3.20M-15.5%
LifeMD, Inc. (LFMD)2025-12-31$1.87M+27.8%
SBC Medical Group Holdings Inc (SBC)2025-12-31$1.40M-45.4%
Airsculpt Technologies, Inc. (AIRS)2025-12-31$2.40M-82.8%
Hims & Hers Health, Inc. (HIMS)2025-12-31$242.60M+359.5%
Teladoc Health, Inc. (TDOC)2025-12-31$8.89M-17.6%
HealthLynked Corp (HLYK)2024-12-31$2.6K+73.2%

Compare STLN, LFMD, SBC, AIRS side by side · Screen every company in Services-Offices & Clinics of Doctors of Medicine ↗